237 related articles for article (PubMed ID: 16010251)
41. The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients.
Spanu A; Ginesu F; Pirina P; Schillaci O; Farris A; Chessa F; Madeddu G; Falchi A; Madeddu G
Oncol Rep; 2003; 10(6):1701-7. PubMed ID: 14534682
[TBL] [Abstract][Full Text] [Related]
42. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Picardi V; Cannas P; Colella AC
Nucl Med Commun; 1997 Sep; 18(9):839-45. PubMed ID: 9352550
[TBL] [Abstract][Full Text] [Related]
43. The impact of transmission-emission misregistration on the interpretation of SPET/CT myocardial perfusion studies and the value of misregistration correction.
Apostolopoulos DJ; Gąsowska M; Savvopoulos CA; Skouras T; Spyridonidis T; Andrejczuk A; Vassilakos PJ
Hell J Nucl Med; 2015; 18(2):114-21. PubMed ID: 26187210
[TBL] [Abstract][Full Text] [Related]
44. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
45. Imaging of brain tumors in AIDS patients by means of dual-isotope thallium-201 and technetium-99m sestamibi single-photon emission tomography.
De La Peña RC; Ketonen L; Villanueva-Meyer J
Eur J Nucl Med; 1998 Oct; 25(10):1404-11. PubMed ID: 9818280
[TBL] [Abstract][Full Text] [Related]
46. The role of scintigraphy in the evaluation of brain malignancies.
Stathaki MI; Koukouraki SI; Karkavitsas NS
Hell J Nucl Med; 2010; 13(3):264-72. PubMed ID: 21193883
[TBL] [Abstract][Full Text] [Related]
47. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
48. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
49. Breast scintigraphy today: indications and limitations.
Schillaci O; Buscombe JR
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S35-45. PubMed ID: 15103505
[TBL] [Abstract][Full Text] [Related]
50. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
[TBL] [Abstract][Full Text] [Related]
51. Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Lonneux M; Delval D; Bausart R; Moens R; Willockx R; Van Mael P; Declerck P; Jamar F; Zreik H; Pauwels S
Nucl Med Commun; 1998 Nov; 19(11):1047-54. PubMed ID: 9861621
[TBL] [Abstract][Full Text] [Related]
52. Molecular breast imaging with gamma emitters.
Schillaci O; Spanu A; Danieli R; Madeddu G
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):340-51. PubMed ID: 24322791
[TBL] [Abstract][Full Text] [Related]
53. The value of SPET/CT in chronic osteomyelitis.
Horger M; Eschmann SM; Pfannenberg C; Storek D; Dammann F; Vonthein R; Claussen CD; Bares R
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1665-73. PubMed ID: 14523585
[TBL] [Abstract][Full Text] [Related]
54. CT-MIBI image fusion: transmission and emission tomography for localization of bronchogenic carcinoma and nodal metastasis.
Sharma R; Bhatnagar P; Mondal A; Sawroop K; Datta M; Kashyap R
Clin Nucl Med; 2006 Jun; 31(6):355-6. PubMed ID: 16714901
[No Abstract] [Full Text] [Related]
55. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms.
Pfannenberg AC; Eschmann SM; Horger M; Lamberts R; Vonthein R; Claussen CD; Bares R
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):835-43. PubMed ID: 12682789
[TBL] [Abstract][Full Text] [Related]
56. SPET/CT image co-registration in the abdomen with a simple and cost-effective tool.
Förster GJ; Laumann C; Nickel O; Kann P; Rieker O; Bartenstein P
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):32-9. PubMed ID: 12483407
[TBL] [Abstract][Full Text] [Related]
57. Prospective evaluation of technetium-99m ECD SPET in mild traumatic brain injury for the prediction of sustained neuropsychological sequels.
Mehrazin M; Nezameddini-Kachooei SA; Fallahi B; Derakhshan MK; Beiki D; Ghodsi SM; Assadi M; Pooyafard F; Eftekhari M
Hell J Nucl Med; 2011; 14(3):243-50. PubMed ID: 22087443
[TBL] [Abstract][Full Text] [Related]
58. SPECT-CT in Radiotherapy Planning, with Main Reference to Patients with Breast Cancer.
Sergieva S; Mihaylova I; Alexandrova E; Dimcheva M; Mansi L
Curr Radiopharm; 2015; 8(1):9-18. PubMed ID: 25808957
[TBL] [Abstract][Full Text] [Related]
59. Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery?
De Vincentis G; Scopinaro F; Varvarigou A; Ussof W; Schillaci O; Archimandritis S; Corleto V; Longo F; Delle Fave G
Tumori; 2002; 88(3):S28-30. PubMed ID: 12365378
[TBL] [Abstract][Full Text] [Related]
60. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
